A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Top Cited Papers
Open Access
- 24 September 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 8 (1), 1-15
- https://doi.org/10.1038/s41598-018-32651-4
Abstract
Most clinical studies of Cannabis today focus on the contents of two phytocannabinoids: (-)-Δ9-trans-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), regardless of the fact that the plant contains over 100 additional phytocannabinoids whose therapeutic effects and interplay have not yet been fully elucidated. This narrow view of a complex Cannabis plant is insufficient to comprehend the medicinal and pharmacological effects of the whole plant. In this study we suggest a new ESI-LC/MS/MS approach to identify phytocannabinoids from 10 different subclasses, and comprehensively profile the identified compounds in diverse medical Cannabis plants. Overall, 94 phytocannabinoids were identified and used for profiling 36 of the most commonly used Cannabis plants prescribed to patients in Israel. In order to demonstrate the importance of comprehensive phytocannabinoid analysis before and throughout medical Cannabis clinical trials, treatments, or experiments, we evaluated the anticonvulsant effects of several equally high-CBD Cannabis extracts (50% w/w). We found that despite the similarity in CBD contents, not all Cannabis extracts produced the same effects. This study’s approach for phytocannabinoid profiling can enable researchers and physicians to analyze the effects of specific Cannabis compositions and is therefore critical when performing biological, medical and pharmacological-based research using Cannabis.Keywords
This publication has 53 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposesPhytochemistry, 2010
- In silico analysis of alpha1-antitrypsin variants: the effects of a novel mutationGenetics and Molecular Biology, 2010
- In silicio expression analysis of PKS genes isolated from Cannabis sativa L.Genetics and Molecular Biology, 2010
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In VivoThe Journal of pharmacology and experimental therapeutics, 2009
- Chemical constituents of marijuana: The complex mixture of natural cannabinoidsLife Sciences, 2005
- Constituents of cannabis sativa L. XVI. A possible decomposition pathway of Δ9‐tetrahydrocannabinol to cannabinolJournal of Heterocyclic Chemistry, 1979
- Mass Spectrometry of CannabinoidsJournal of Pharmaceutical Sciences, 1977
- Cannabis. VI. Cannabicyclolic AcidCHEMICAL & PHARMACEUTICAL BULLETIN, 1972